![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 19, 14573-14578, May 12, 2000
From the Departments of Medicine and Microbiology-Immunology and
¶ Veterans Affairs Medical Center, University of California, San
Francisco, California 94143-0711 and § Department of
Medicine, Hematology Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts 02115
Lysophosphatidic acid (LPA) in biological fluids
binds to serum albumin and other proteins that enhance its effects on
cellular functions. The actin-severing protein gelsolin binds LPA with an affinity (Kd = 6 nM) similar to that
of the G protein-coupled LPA receptors encoded by endothelial
differentiation genes 2, 4, and 7 (Edg-2, -4, and -7 receptors) and
greater than that of serum albumin (Kd = 360 nM). At concentrations of 10% or less of that in plasma,
which are observed in fluids of injured tissues, purified and
recombinant gelsolin augment LPA stimulation of nuclear signals and
protein synthesis in rat cardiac myocytes (RCMs) that express Edg-2 and
-4 receptors. At concentrations of 20% or more of that in plasma,
gelsolin suppresses LPA stimulation of RCMs. The lack of effect of
gelsolin on RCM responses to monoclonal anti-Edg-4 receptor antibody
plus a phorbol ester without LPA attests to its specificity for LPA
delivery and the absence of post-receptor effects. Inhibition of
gelsolin binding and cellular delivery of LPA by
L-
Gelsolin Binding and Cellular Presentation of
Lysophosphatidic Acid*
,
-phosphatidylinositol-4,5-bisphosphate (PIP2) and
peptides constituting the two PIP2 binding domains of gelsolin suggests
competition between LPA and PIP2 for the same sites. Thus, delivery of
LPA to RCMs is affinity-coupled to Edg receptors by gelsolin in a
PIP2-regulated process.
*
This work was supported in part by National Institutes of
Health Grants HL31809 (to E. J. G.) and HL54253 (to T. P. S.) and a
Merit Review grant from the Department of Veterans Affairs Research Service (to J. S. K.). These data were presented in part at the 1999 annual meeting of the American Society for Biochemistry and Molecular
Biology (41).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: University of
California, UB8B, Box 0711, 533 Parnassus, San Francisco, CA
94143-0711. Tel.: 415-476-5339; Fax: 415-476-6915; E-mail:
egoetzl@itsa.ucsf.edu.
This article has been cited by other articles:
![]() |
R. Bucki, F. J. Byfield, A. Kulakowska, M. E. McCormick, W. Drozdowski, Z. Namiot, T. Hartung, and P. A. Janmey Extracellular Gelsolin Binds Lipoteichoic Acid and Modulates Cellular Response to Proinflammatory Bacterial Wall Components J. Immunol., October 1, 2008; 181(7): 4936 - 4944. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-U. Chen, C.-H. Chou, H. Lee, C.-H. Ho, C.-W. Lin, and Y.-S. Yang Lysophosphatidic Acid Up-Regulates Expression of Interleukin-8 and -6 in Granulosa-Lutein Cells through Its Receptors and Nuclear Factor-{kappa}B Dependent Pathways: Implications for Angiogenesis of Corpus Luteum and Ovarian Hyperstimulation Syndrome J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 935 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, A. Bialkowska, R. Rusovici, S. Chanchevalap, H. Shim, J. P. Katz, V. W. Yang, and C. C. Yun Lysophosphatidic Acid Facilitates Proliferation of Colon Cancer Cells via Induction of Kruppel-like Factor 5 J. Biol. Chem., May 25, 2007; 282(21): 15541 - 15549. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. DiNubile Plasma gelsolin: in search of its raison d'etre. Focus on "Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin" Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1240 - C1242. [Full Text] [PDF] |
||||
![]() |
T. M. Osborn, C. Dahlgren, J. H. Hartwig, and T. P. Stossel Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1323 - C1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hollenback, L. Bonham, L. Law, E. Rossnagle, L. Romero, H. Carew, C. K. Tompkins, D. W. Leung, J. W. Singer, and T. White Substrate specificity of lysophosphatidic acid acyltransferase {beta}--evidence from membrane and whole cell assays J. Lipid Res., March 1, 2006; 47(3): 593 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takahashi, Y. Takeishi, T. Seidler, T. Arimoto, H. Akiyama, Y. Hozumi, Y. Koyama, T. Shishido, Y. Tsunoda, T. Niizeki, et al. Adenovirus-Mediated Overexpression of Diacylglycerol Kinase-{zeta} Inhibits Endothelin-1-Induced Cardiomyocyte Hypertrophy Circulation, March 29, 2005; 111(12): 1510 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bagga, K. S. Price, D. A. Lin, D. S. Friend, K. F. Austen, and J. A. Boyce Lysophosphatidic acid accelerates the development of human mast cells Blood, December 15, 2004; 104(13): 4080 - 4087. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cummings, Y. Zhao, D. Jacoby, E. W. Spannhake, M. Ohba, J. G. N. Garcia, T. Watkins, D. He, B. Saatian, and V. Natarajan Protein Kinase C{delta} Mediates Lysophosphatidic Acid-induced NF-{kappa}B Activation and Interleukin-8 Secretion in Human Bronchial Epithelial Cells J. Biol. Chem., September 24, 2004; 279(39): 41085 - 41094. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Rothenbach, B. Dahl, J. J. Schwartz, G. E. O'Keefe, M. Yamamoto, W. M. Lee, J. W. Horton, H. L. Yin, and R. H. Turnage Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction J Appl Physiol, January 1, 2004; 96(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. DiNubile, T. P. Stossel, O. C. Ljunghusen, J. L. M. Ferrara, and J. H. Antin Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation Blood, December 15, 2002; 100(13): 4367 - 4371. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sano, D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi, Y. Igarashi, and G. Tigyi Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood J. Biol. Chem., June 7, 2002; 277(24): 21197 - 21206. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Jin, H.-Z. Zhou, P. Zhu, N. Honbo, D. Mochly-Rosen, R. O. Messing, E. J. Goetzl, J. S. Karliner, and M. O. Gray Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCepsilon knockout mouse hearts Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1970 - H1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Jin, H.-Z. Zhou, P. Zhu, N. Honbo, D. Mochly-Rosen, R. O. Messing, E. J. Goetzl, J. S. Karliner, and M. O. Gray Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCepsilon knockout mouse hearts Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1970 - H1977. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |